PSA Monitoring & Cancer Surveillance after Prostatectomy
Why PSA Monitoring Continues after Surgery
Prostatectomy removes the prostate gland — the primary source of prostate-specific antigen (PSA) in the body. After prostatectomy, PSA is expected to fall to a very low or undetectable level, depending on the sensitivity of the laboratory assay used. That result is reassuring, but it is not the end of surveillance.
PSA monitoring after prostatectomy is ongoing because prostate cancer cells, if any remain or return, can produce PSA even without a prostate gland present. Regular testing allows your care team to detect any change early — when options for additional treatment are most effective.
Understanding what your PSA results mean, and what they do not mean, can help you approach each test with more confidence and less fear.
What 'Undetectable' PSA Means
After prostatectomy, the goal is for PSA to fall to a level that is undetectable or very low on the assay being used. Because laboratory assays differ in sensitivity, the lowest reportable PSA value varies from one laboratory to another.
An undetectable PSA does not guarantee that no cancer cells remain anywhere in the body. It means that if any cells are present, they are not producing enough PSA to be detected at this time. This is why monitoring continues even when results are consistently reassuring.
Some practices use ultra-sensitive PSA assays that can detect levels as low as 0.01 ng/mL or 0.003 ng/mL. These tests can identify very small PSA rises earlier than standard assays. Ask your urologist which type of test your lab uses and what threshold they consider clinically significant for your specific situation.
How Often PSA Is Monitored
PSA testing schedules after prostatectomy vary by practice and by individual risk factors, but a common approach follows a pattern of more frequent testing in the early years after surgery, with intervals lengthening as results remain stable.
| Time after Surgery | Example Follow-Up Schedule |
|---|---|
| First year | Every 3–6 months |
| Years 2–5 | Every 6 months |
| After 5 years (if stable) | Annually |
Your urologist may recommend a different schedule based on your pathology results, surgical margins, Gleason grade, and other individual factors. Men with higher-risk features at the time of surgery are often monitored more closely in the early years.
After prostatectomy, I remind patients that PSA monitoring is not simply about watching for cancer to return. It is part of survivorship care.
An undetectable PSA is something to celebrate, but continued testing is still important. I encourage patients to know their PSA results, keep track of the trend over time, and understand when their next test is due. One PSA value is only one point in time; the pattern over time gives the care team much more information.
I also encourage patients to ask what their results mean for them, based on their pathology and individual risk factors. Knowing what the care team is watching for — and what would happen if the PSA ever became detectable — can make surveillance feel less frightening and more like an active plan for staying well.
Monitoring does not mean we expect the cancer to return. It means we are continuing to care for you after treatment.
Understanding Biochemical Recurrence
Biochemical recurrence (BCR) after prostatectomy has traditionally been defined as a PSA of 0.2 ng/mL or higher, confirmed by a subsequent PSA measurement. However, your care team may begin evaluating a detectable or rising PSA before it reaches this level, particularly when other clinical or pathology findings suggest higher risk.
A diagnosis of biochemical recurrence does not mean the cancer has spread to other organs, and it does not necessarily mean immediate treatment is required. It means that PSA is detectable and that your care team will want to investigate further to understand what is happening and what, if anything, should be done next.
Many men with biochemical recurrence after prostatectomy never develop metastatic disease. The significance of a rising PSA depends on how quickly it is rising (PSA doubling time), how long after surgery it appeared, and the original pathology findings. Your urologist will use these factors to guide next steps.
When biochemical recurrence is identified, additional imaging — such as a PSMA PET scan — may be recommended to look for evidence of where recurrent cancer may be located, such as the surgical bed, lymph nodes, or elsewhere. This information shapes treatment decisions.
PSA Doubling Time and Velocity
Not all rising PSA values carry the same significance. Two key measures help your care team interpret a rising PSA:
How long it takes for the PSA level to double. A longer doubling time — more than 12 months — is generally associated with a slower-growing process and a lower short-term risk of metastasis. A shorter doubling time — particularly less than 6 months — can be associated with more aggressive disease and may influence how quickly the care team recommends further evaluation or treatment.
The rate of change in PSA over time, measured in ng/mL per year. Rapid increases in velocity are a signal that warrants closer attention, even when absolute PSA values remain low.
These calculations require multiple PSA measurements over time, which is one reason consistent monitoring — even when results are stable — is important. A single elevated value is less meaningful than a pattern.
I pray my PSA stays undetectable. I know that if it doesn't, I may need additional treatment, possibly as soon as six months after surgery. So yes, I still worry.
At the same time, I know we have a plan. If the next PSA changes, we'll recheck it and then decide what comes next. I try not to get ahead of myself and worry about treatment I may never need.
For now, my PSA is undetectable, and that's what I want to focus on.
If something changes, we'll cross that bridge when we get to it.
Living with Surveillance — Managing PSA Anxiety
For many men, the period leading up to a PSA test — and the wait for results — is among the most stressful parts of life after prostatectomy. This is sometimes called "PSA anxiety," and it is widely reported among prostate cancer survivors. It is a normal response to ongoing uncertainty, not a sign of weakness.
PSA anxiety tends to be most intense in the first few years after surgery, when testing is more frequent and the memory of diagnosis is recent. For many men, it eases over time as results remain stable and confidence in the monitoring process grows.
Ask your urologist to explain what a result would need to look like before they would recommend any change in management — knowing the threshold can reduce fear of ambiguous numbers. Schedule tests at a time when you can receive results promptly rather than waiting over a weekend. Stay physically active; exercise has well-documented benefits for anxiety in cancer survivors. Connect with other prostate cancer survivors who understand the experience of living with surveillance.
If PSA anxiety is significantly affecting your quality of life — interfering with sleep, relationships, or daily function — it is worth discussing with your care team. Referral to a psychologist or oncology social worker experienced with cancer survivorship is a reasonable and effective option.
My husband has had two PSA tests since surgery — one at six weeks and another at three months. Truthfully, I don't worry about the numbers as much as my husband does. The PSA is out of my control. What I can do is help with the anxiety and fears that come before the next test.
We talk. We enjoy everyday life. We try to be grateful for where we are right now. We also decided to celebrate after each PSA. Instead of allowing every test to become something we only fear, we made it an opportunity to recognize how far we have come.
A big part of my attitude comes from my faith. At the beginning of this journey, I put my faith in God to guide us and take care of us along the way. That doesn't mean I believe everything will always turn out exactly as I hope. It means I believe we won't be alone in whatever comes.
Do I fear his next PSA? No. I have to take this journey one day at a time and enjoy the life we have today.
We'll worry about tomorrow, tomorrow.
Questions to Ask Your Urologist
Being an informed participant in your surveillance plan can reduce uncertainty and help you feel more in control of your care. Consider asking:
- What PSA level would prompt you to recommend further evaluation or treatment?
- What type of PSA assay does your lab use, and how sensitive is it?
- Based on my pathology, what is my estimated risk of biochemical recurrence?
- If my PSA rises, what would the next steps look like?
- How long after surgery is biochemical recurrence most likely to appear, if it occurs?
- Are there lifestyle factors — such as diet, exercise, and maintaining a healthy weight — that may support my overall health and prostate cancer survivorship?
Surveillance Is Part of Survivorship
PSA monitoring is not a sign that something is wrong. It is a structured, evidence-based approach to catching any change early — when the most options are available. For the majority of men after prostatectomy, PSA results remain undetectable and stable for years.
Living with ongoing surveillance is one of the realities of prostate cancer survivorship. It requires a degree of tolerance for uncertainty that most men develop over time. Understanding what the numbers mean — and what they do not mean — is one of the most useful tools for navigating that uncertainty.